Evidence map›Paper›PMID 41760813›Full record

ReviewNature chemical biology2026

Defining and refining the cysteine redoxome through sulfur chemical biology.

Kate S Carroll, Jing Yang

Erratum issuedAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Kate S CarrollDepartment of Chemistry and Biochemistry, Charles E. Schmidt College of Science, Florida Atlantic University, Jupiter, FL, USA. kcarro14@fau.edu.ORCID http://orcid.org/0000-0002-7624-9617
Jing YangGuangzhou National Laboratory, Guangzhou International Bio Island, Guangzhou, China. yangjing@ncpsb.org.cn.ORCID http://orcid.org/0000-0001-8486-273X

Funding

Sulfur Metabolism in Human PathogensR01GM087638 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CARROLL, KATE SUZANNE · 2009 to 2025
$5.0M
Probing the role of cysteine sulfenylation in cell signalingR01GM102187 · NIGMS · UNIVERSITY OF FLORIDA · PI Kate Suzanne Carroll · 2012 to 2026
$4.6M
Nucleophile-Fragment Screening for Site-Specific Covalent Ligand Discovery in Opioid Receptor SignalingR21DA059363 · NIDA · UNIVERSITY OF FLORIDA · PI CARROLL, KATE SUZANNE · 2024 to 2025
$425k
Targeting Oxidized PTP1B for Anticancer Drug DiscoveryR03CA289646 · NCI · UNIVERSITY OF FLORIDA · PI CARROLL, KATE SUZANNE · 2024 to 2025
$173k
National Science Foundation (NSF) 2446734NCI NIH HHS R03 CA289646NIDA NIH HHS R21 DA059363NIGMS NIH HHS R01 GM087638NIGMS NIH HHS R01 GM102187U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) GM087638U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) GM102187
6 · The paper itself

Abstract

Cysteine is one of the rarest amino acids yet exerts a profound influence on biology through the exceptional chemistry of its thiol group. Tunable acidity, high nucleophilicity and access to multiple oxidation states position cysteine as both a dominant cellular redox buffer and a privileged regulatory site. Chemoproteomics has revealed a vast, dynamic cysteine redoxome in which oxidative post-translational modifications act as sensors, switches and buffers across metabolism, signaling and stress responses, respectively. This study advances the following three frameworks: (1) separating intrinsic reactivity from redox sensitivity and regulatory function; (2) using probe chemistry to capture metastable intermediates with site-level precision; and (3) integrating ratiometric measurements with occupancy, exposure and flux to decode redox dynamics. Case studies show how ratiometric chemoproteomics resolves distinct oxoform kinetics, links enzymatic repair to function and exposes the cysteine redoxome as a dynamic regulatory layer and frontier for therapeutic targeting.

Indexed as

CysteineSulfurHumansKineticsOxidation-ReductionProtein Processing, Post-TranslationalProteomicsCysteineSulfur

Identifiers

PMID41760813

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.